Akari Therapeutics Plc - American Depositary Shares (NQ:AKTX)

8.225 +0.125 (+1.54%)

Delayed Quote Updated: 3:59 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Akari Therapeutics Plc - American Depositary Shares

< Previous 1 2 3 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 20, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 03, 2023

On Tuesday, 31 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 29, 2022

Via Benzinga

Why Canoo Shares Are Trading Higher By Over 12%? Here Are 32 Stocks Moving In Friday's Mid-Day Session ↗

November 25, 2022

Gainers Peak Bio, Inc. (NYSE: PKBO) shares jumped 49.1% to $7.08.

Via Benzinga

Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session ↗

December 21, 2022

Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical...

Via Benzinga

S&P 500 Rises 1%, InMed Pharmaceuticals Shares Spike Higher ↗

September 12, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Monday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022 ↗

December 05, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

September 12, 2022

During Monday's session, 38 stocks hit new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 12, 2022

Via Benzinga

Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.

Via Benzinga

Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session ↗

September 12, 2022

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.

Via Benzinga

Dow Jumps 250 Points; Crude Oil Rises Over 1% ↗

September 12, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 250 points on Monday.

Via Benzinga

Why Akari Therapeutics Shares Are Getting Obliterated ↗

September 12, 2022

Akari Therapeutics PLC (NASDAQ: AKTX) shares are trading lower by 26.92% to $0.76 Monday morning after the company announced a $12.75 million registered direct offering. What Else?

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 12, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 28, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 28, 2022

Via Benzinga

This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday ↗

August 01, 2022

Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 27, 2022

During Monday's session, 77 companies made new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 19, 2022

Gainers Radius Health (NASDAQ:RDUS) stock moved upwards by 18.8% to $6.94 during Thursday's after-market session. The company's market cap stands at $330.1 million.

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation ↗

May 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 30, 2021

Gainers Kiora Pharmaceuticals (NASDAQ:KPRX

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 17, 2021

Gainers Rani Therapeutics Hldgs (NASDAQ:RA...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 07, 2021

Gainers Dare Bioscience (NASDAQ:DARE) shares increased by 51.97% to $2.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 04, 2021

Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $226.7...

Via Benzinga

Akari Therapeutics' Nomacopan Secures Expediated Review Tag For Blistering Skin Disorder ↗

April 28, 2021

The FDA has granted Fast Track designation to Akari Therapeutics Plc's (NASDAQ: AKTX) nomacopan to treat patients with moderate and severe Bullous...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 28, 2021

Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market session. The company's market cap stands at $102.7...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 19, 2021

Gainers Obalon Therapeutics (NASDAQ:OBLN) shares moved upwards by 6.04% to $2.63 during Monday's after-market session. At the close, Obalon Therapeutics's trading volume...

Via Benzinga

25 Stocks Moving in Tuesday's Pre-Market Session ↗

April 13, 2021

Gainers Dragon Victory International Limited (NASDAQ: LYL) rose 52.1% to $2.16 in pre-market trading after dropping around 8% on Monday. Mackinac Financial Corporation (NASDAQ:...

Via Benzinga

Akari Therapeutics' To Go With Pivotal Bullous Pemphigoid Study With Nomacopan ↗

April 12, 2021

The FDA has opened the investigational new drug application for Phase 3 trial for Akari Therapeutics Plc's (NASDAQ: AKTX) lead drug candidate,...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.